Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/223515
Reaching the point-of-no-return: the cornerstone of glioblastoma treatment?
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
The activation of cellular death programs does not necessarily predetermine an inevitable outcome. Identifying the precise moment when a cell irreversibly transitions from life to death presents a significant challenge in its assessment and measurement. In this review, we explore the critical alterations in cellular structures that have been proposed as the point-of-no-return. Using glioblastoma as a model-one of the most aggressive and lethal tumor types with a remarkable ability to evade cell death-we highlight the challenge of reaching the point-of-no-return. Glioblastoma cells often exhibit impaired function of the apoptotic endonuclease, DFF40/CAD/CPAN, leading to incomplete apoptosis and genomic instability. The sublethal activation of DFF40/CAD/CPAN not only allows tumor cells to survive but can also drive more aggressive phenotypes and enhance therapeutic resistance. We underscore the need to reassess glioblastoma treatment strategies from broad cytotoxic approaches to more targeted therapies that exploit specific vulnerabilities within regulated cell death (RCD) pathways.
Subject
Subject (English)
Citation
Citation
ALEMANY, Montse, BRUNA, Jordi and YUSTE, Victor J. Reaching the point-of-no-return: the cornerstone of glioblastoma treatment?. Neuro-Oncology Advances. 2025. Vol. 7, num. 1. ISSN 2632-2498. [consulted: 10 of August of 2026]. Available at: https://hdl.handle.net/2445/223515